Genmab — Marts 2021
-
Indeed
-
Symphony Health data. Totalt Darzalex salg i februar var USD 265M. 17% hoejere end i januar. Faspro udgjorde 56%.
-
But 46% higher than February 2020. Nice growth year over year...
-
19 US arbejsdage både i januar og februar
-
-
December 2020 had 22 working days
-
Daily volume in December 2020 was 12.6M. February 2021 had 13.9M
-
Hvorfor skal det tage mere end 1 år i filing procedure?
-
Første salg i 2025? Da Darzalex blev godkendt gik der 3 dage indtil første salg...
-
Korrekt
kan selvfølgelig også være det bliver Q2, 3 eller worst case Q4 - men med de store summer der pumpes i projektet og Jans konservative måde at udtale sig på hælder jeg til H1 og som investerings case satser jeg på Q1. Hellere komme lidt for tidligt ind i casen end for sent. -
Seagen
@SeagenGlobal
This year,
@AmericanCancer
estimates 14K new cases of #cervicalcancer will be diagnosed in the US. We’re working to advance cancer care by initiating our innovaTV 301 study with
@Genmab
in recurrent and metastatic forms of this disease. #SGO21 https://twitter.com/SeagenGlobal/status/1374722673184489476 -
recruitment starting in the US so far https://clinicaltrials.gov/ct2/history/NCT04697628?A=3&B=4&C=merged#StudyPageTop
-
Ok, fandt det: https://www.proinvestor.com/boards/90155/Darzalex-2020 .. og har nu bogmærket det
-
Det er ikke SH tal..men real sale..;-)
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind